Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMIC CMO is a leading contract development and manufacturing organization (CDMO) and a core subsidiary of the Japanese CMIC Group. The company provides comprehensive support for drug development and commercial manufacturing, specializing in a wide range of dosage forms including oral solids, topicals, and sterile injectables. With facilities in Japan and the United States, CMIC CMO offers services ranging from formulation development and clinical trial material manufacturing to full-scale commercial production and packaging. They are particularly recognized for their expertise in high-potency compounds and orphan drug manufacturing, serving a global clientele of pharmaceutical and biotech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMIC CMO.